Clinical trial
A Phase 1 Study of MORAb-003 in Patients With Solid Tumor
NCT01049061 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of MORAb-003 in Patients With Solid Tumor
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- February 28, 2013
- Enrollment
- 16 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neoplasms, solid tumor